| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesiology,
Department of Anesthesiology and Pain Management, Temple University Hospital, Philadelphia, Pennsylvania
Address correspondence and reprint requests to Robert Friedman, MD, FACP, Division of Pain Medicine, Cooper Hospital University Medical Center, One Cooper Plaza, Camden, NJ 08103. Address e-mail to DrRFriedman{at}aol.com
IMPLICATIONS: Oral Ketamine, an NMDA receptor antagonist, can be used to treat restless legs syndrome. A mechanism for the efficacy of this treatment is discussed.
This article has been cited by other articles:
![]() |
C. C. Alpert, D. P. Tobin, and S. F. Dierdorf Physostigmine for the Acute Treatment of Restless Legs Syndrome Anesth. Analg., September 1, 2005; 101(3): 726 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Fawcett and R. Friedman Ketamine for Restless Legs Syndrome * Response Anesth. Analg., April 1, 2003; 96(4): 1238 - 1239. [Full Text] [PDF] |
||||
|